Cronos Group Inc. (CRON.TO)

3.7500 -0.3000 (-7.41%) At close: 04:00PM EDT

Cronos Group Inc.

111 Peter Street
Suite 300
Toronto, ON M5V 2H1
Canada
416 504 0004
https://www.thecronosgroup.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 356

Key executives

Name	Title	Pay	Exercised	Year born
Mr. James Andrew McGinness III	VP, Controller & Principal Accounting Officer	N/A	N/A	1979
Mr. Shayne J. Laidlaw	Director of Investor Relations & Strategy	N/A	N/A	N/A
Mr. Adam Wagner	Senior VP & Head of Cronos Israel	N/A	N/A	1983

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Corporate governance

Cronos Group Inc.’s ISS governance QualityScore as of 29 April 2024 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.